MAY 19, 2017 3:57 PM PDT

How the Brain Protects Itself from West Nile Virus

WRITTEN BY: Kara Marker

The same gene in the brain that codes for a biochemical “self-destruct trigger” in some tissues protects neurons from West Nile virus without causing cell death. From the University of Washington, researchers are studying how the gene, RIPK3, works to keep the peace.

West Nile virus-infected brain neurons. Credit: Brian Daniels

West Nile virus is a mosquito-transmitted disease first detected in the United States in 1999. Infection only develops in about 20-30 percent of people exposed to West Nile virus, and for those who are infected, severe symptoms are very rare. When they do occur though, they include coma, tremors, seizures, and paralysis.

Recent studies in mice show that despite RIPK3’s reputation in other organs of the body, neuron sacrifice is not necessary to eliminate West Nile in the brain and order up a response from the immune system. Instead, the chemical pathway simultaneously preserves neurons and recruits immune chemicals and virus-fighting cells to the scene of the crime.

Instead of sacrificing neurons, RIPK3 activation in the brain results in chemokine recruitment, immune chemicals that in turn attract white blood cells to do the fighting against West Nile virus. These white blood cells eliminate West Nile from the brain not by suppressing viral reproduction, but by causing inflammation. Because of this approach, RIPK3 is likely involved in neurodegenerative disorders and autoimmune disease in the brain. However, targeting RIPK3 as a treatment for these conditions would have to include a careful balance, to ensure the brain is not left unprotected against viruses like West Nile.

"RIPK3 acts as part of the milieu of signals that support anti-viral inflammation in the brain," explained the lead author of the study, Brian Daniels.

During their studies with RIPK3 in mice, researchers procured RIPK3 deficient mice and saw that these mutants were highly susceptible to West Nile virus infection, a direct result of lacking “chemokine-generated neuroinflammation.”

In addition to likely playing a part in autoimmune disease, RIPK3’s unique role in the brain indicates that there may be other central nervous functions for the gene that scientists have yet to discover. Senior author Andrew Oberst says that there’s something special about neurons that must drive RIPK3 to suppress its self-destructive nature in the brain, “perhaps because they are non-renewable and too important to undergo cell death.”

The present study was published in the journal Cell.

Sources: CDC, European Centre for Disease Prevention and Control, University of Washington Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
NOV 11, 2021
Cell & Molecular Biology
Why Arthritis Tends to Affect the Same Joints Repeatedly
NOV 11, 2021
Why Arthritis Tends to Affect the Same Joints Repeatedly
While arthritis may not cause pain all the time, when it flares, it tends to recur in the same joints. This can create s ...
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 23, 2021
Immunology
Hitting the Anti-inflammatory Bullseye to Treat IBD
DEC 23, 2021
Hitting the Anti-inflammatory Bullseye to Treat IBD
Fifty percent—that’s the percentage of patients with inflammatory bowel disease (IBD) who experience long-te ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
JAN 17, 2022
Cancer
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
JAN 17, 2022
High Fiber Diet Provides a Helpful Boost to Melanoma Treatment
Immune checkpoint inhibitors (ICIs) have become a promising new treatment for advanced cancers, including melanoma. Immu ...
Loading Comments...